High resolution structure determination is necessary to fully clarify the molecular details of peptide- and antibody-bound class B GPCRs, which is important for the development of new and improved therapeutics targeting this class of GPCRs
2 They also cite internal observational data from 3,250 patients
Rather than being direct alternatives, they are often viewed as complementary research tools
Australian Dietary Guidelines
Nonsteroidal anti-inflammatory drugs (NSAIDs)
The purpose of the NDA is to provide FDA reviewers with enough information to make the following key decisions: Comprehending whether the drug is safe and effective in its proposed use(s) Comprehending whether the benefits of the drug outweigh the risks Determining whether the drug's submitted labeling (package insert) is appropriate, and what it should include Determining whether the methods used in manufacturing the drug and the controls used to maintain its quality are sufficient to maintain the drug's identity, strength, quality, and purity